Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

18. juli 2006 oppdatert av: Eli Lilly and Company
The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Fase

  • Fase 2

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Forente stater
    • Alabama
      • Birmingham, Alabama, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Huntsville, Alabama, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Arizona
      • Peoria, Arizona, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Tucson, Arizona, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Arkansas
      • Little Rock, Arkansas, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • California
      • Bakersfield, California, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Pico Rivera, California, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • San Diego, California, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Santa Ana, California, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Colorado
      • Denver, Colorado, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Connecticut
      • Waterbury, Connecticut, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • West Hartford, Connecticut, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Florida
      • Clearwater, Florida, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Kissimmee, Florida, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Ocala, Florida, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • St Petersburg, Florida, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Georgia
      • Decatur, Georgia, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Hawaii
      • Honolulu, Hawaii, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Illinois
      • Orland Park, Illinois, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Peoria, Illinois, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Indiana
      • Evansville, Indiana, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Kansas
      • Wichita, Kansas, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Kentucky
      • Louisville, Kentucky, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Maryland
      • Baltimore, Maryland, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Minnesota
      • Edina, Minnesota, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Minneapolis, Minnesota, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • New York
      • Endwell, New York, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Great Neck, New York, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • North Carolina
      • Charlotte, North Carolina, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Fayetteville, North Carolina, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Oregon
      • Eugene, Oregon, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Pennsylvania
      • Allentown, Pennsylvania, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Fleetwood, Pennsylvania, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Lansdale, Pennsylvania, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Philadelphia, Pennsylvania, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • South Carolina
      • MT Pleasant, South Carolina, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Texas
      • San Antonio, Texas, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Utah
      • Salt Lake City, Utah, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Virginia
      • Lebanon, Virginia, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
    • Washington
      • Renton, Washington, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)
      • Spokane, Washington, Forente stater
        • For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Diagnosis of Type 2 Diabetes for at least 3 months.
  • Diabetes managed with diet and exercise alone or with either metformin or sulfonylurea alone as an adjunct to diet and exercise.
  • Diabetes therapy must be unchanged for at least 3 months prior to screening.
  • Females must be of non-childbearing potential (surgically sterilized or at least 1 year post-menopausal, as defined by cessation of menses). Female patients who are not surgically sterilized and who are less than or equal to 45 years should have their post-menopausal status confirmed by FSH greater that 30ng/mL at screening.

Exclusion Criteria:

  • Current use of insulin or any antidiabetic agent other than a sulfonylurea agent or metformin.
  • Current use of metformin or a sulfonylurea agent in combination.
  • History of liver disease.
  • History of unstable angina (as defined by the Braunwald system), myocardial infarction, or a coronary revascularization procedure within the past 6 months.
  • Currently suspected carcinoma or history of carcinoma in the last 5 years, with the exception of excised superficial lesions such as basal cell carcinoma and squamous cell carcinoma of the skin.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Eli Lilly and Company

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Datoer for studieregistrering

Først innsendt

21. juli 2003

Først innsendt som oppfylte QC-kriteriene

21. juli 2003

Først lagt ut (Anslag)

22. juli 2003

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

19. juli 2006

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. juli 2006

Sist bekreftet

1. juli 2006

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 5837
  • H7R-MC-GCBD

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Diabetes mellitus, ikke-insulinavhengig

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Cyprus

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

3
Abonnere